FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Evaluating quality of life (QOL) in patients with idiopathic pulmonary fibrosis (IPF) goes beyond lung function numbers. It also shows how treatments affect daily well-being and guides funding, ...
Cystic fibrosis (CF) is the most common inherited metabolic disease in Europe. More than 8,000 people in Germany are affected. Every year, about 150 to 200 children are born with this incurable ...
Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...
Every person with idiopathic pulmonary fibrosis experiences it differently, making each patient's journey unique, says columnist Sam Kirton.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results